Inclination toward herbal remedies as immunity boosters and anti-stress agents during COVID-19 pandemic: A short report.
作者信息
Rasheed Naila
机构信息
Department of Medical Biochemistry, College of Medicine, Qassim University, Buraidah, Saudi Arabia.
出版信息
Int J Health Sci (Qassim). 2021 Jul-Aug;15(4):1-3.
Abstract
摘要
相似文献
1
Inclination toward herbal remedies as immunity boosters and anti-stress agents during COVID-19 pandemic: A short report.新冠疫情期间将草药作为免疫增强剂和抗应激剂的倾向：简短报告
Int J Health Sci (Qassim). 2021 Jul-Aug;15(4):1-3.
2
Inhibitory effect of herbal remedies on 12-O-tetradecanoylphorbol-13-acetate-promoted Epstein-Barr virus early antigen activation.草药对12-O-十四酰佛波醇-13-乙酸酯促进的爱泼斯坦-巴尔病毒早期抗原激活的抑制作用。
Pharmacol Res. 2002 Mar;45(3):213-20. doi: 10.1006/phrs.2001.0936.
3
Interactions between herbal remedies and antirheumatic drugs.草药疗法与抗风湿药物之间的相互作用。
Expert Opin Drug Saf. 2005 Nov;4(6):969-74. doi: 10.1517/14740338.4.6.969.
4
Rapid screening of non-steroidal anti-inflammatory drugs illegally added in anti-rheumatic herbal supplements and herbal remedies by portable ion mobility spectrometry.通过便携式离子迁移谱快速筛查抗风湿草药补充剂和草药疗法中非法添加的非甾体抗炎药。
J Pharm Biomed Anal. 2017 Oct 25;145:203-208. doi: 10.1016/j.jpba.2017.06.002. Epub 2017 Jun 17.
5
Knowledge about COVID-19 and beliefs about and use of herbal products during the COVID-19 pandemic: A cross-sectional study in Saudi Arabia.新冠疫情期间关于新冠病毒的知识以及对草药产品的认知与使用：沙特阿拉伯的一项横断面研究
Saudi Pharm J. 2020 Nov;28(11):1326-1332. doi: 10.1016/j.jsps.2020.08.023. Epub 2020 Sep 1.
6
Prophylactic interventions after delivery of placenta for reducing bleeding during the postnatal period.胎盘娩出后预防产后出血的干预措施。
Cochrane Database Syst Rev. 2013 Nov 26;2013(11):CD009328. doi: 10.1002/14651858.CD009328.pub2.
7
Non-pharmacological remedies for upper respiratory diseases in the pandemic COVID-19 era.大流行 COVID-19 时代治疗上呼吸道疾病的非药物疗法。
J Biol Regul Homeost Agents. 2020 Nov-Dec;34(6 Suppl. 1):41-49.
8
Self-treatment with herbal and other plant-derived remedies--rural Mississippi, 1993.1993年，密西西比州农村地区使用草药及其他植物源药物进行自我治疗的情况。
MMWR Morb Mortal Wkly Rep. 1995 Mar 24;44(11):204-7.
9
[Adverse reactions to herbal remedies: analysis of reported adverse reactions in the Netherlands].[草药疗法的不良反应：荷兰上报不良反应的分析]
Ned Tijdschr Geneeskd. 2013;157(47):A6615.
10
Comprehensive Study of Scientific Evidence and Potential Risk of Herbal Medicine Use for Body Weight Reduction in North West Saudi Arabia.沙特阿拉伯西北部使用草药减轻体重的科学证据及潜在风险的综合研究。
Cureus. 2020 Oct 11;12(10):e10903. doi: 10.7759/cureus.10903.
引用本文的文献
1
The influence of face masks use, immunity boosters and visiting risky places on mental health during the COVID-19 pandemic in Serbia and Republic of Srpska (Bosnia and Herzegovina).在塞尔维亚和斯普斯卡共和国（波斯尼亚和黑塞哥维那）新冠疫情期间，佩戴口罩、使用免疫增强剂以及前往高风险场所对心理健康的影响。
J Health Popul Nutr. 2025 Mar 28;44(1):92. doi: 10.1186/s41043-025-00833-2.
2
Psychological impact of COVID-19 pandemic on Parkinson's disease patients.新冠疫情对帕金森病患者的心理影响。
Heliyon. 2022 Jun 3;8(6):e09604. doi: 10.1016/j.heliyon.2022.e09604. eCollection 2022 Jun.
本文引用的文献
1
Herbal immune-boosters: Substantial warriors of pandemic Covid-19 battle.草药免疫增强剂：抗击大流行新冠病毒的重要战士。
Phytomedicine. 2021 May;85:153361. doi: 10.1016/j.phymed.2020.153361. Epub 2020 Oct 3.
2
Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis.传统中药在抗击 COVID-19 中的前沿作用：临床经验与科学基础。
Phytomedicine. 2021 Jan;80:153337. doi: 10.1016/j.phymed.2020.153337. Epub 2020 Sep 28.
3
Ginger and its active constituents as therapeutic agents: Recent perspectives with molecular evidences.生姜及其活性成分作为治疗药物：基于分子证据的最新观点。
Int J Health Sci (Qassim). 2020 Nov-Dec;14(6):1-3.
4
Herbal plants coordinate COVID-19 in multiple dimensions - An insight analysis for clinically applied remedies.草药植物在多维度协同 COVID-19——临床应用药物的深入分析。
Int J Med Sci. 2020 Oct 22;17(18):3125-3145. doi: 10.7150/ijms.50260. eCollection 2020.
5
Are dopamine and serotonin involved in COVID-19 pathophysiology?多巴胺和血清素是否参与新型冠状病毒肺炎的病理生理过程？
Eur J Psychiatry. 2021 Jan-Mar;35(1):62-63. doi: 10.1016/j.ejpsy.2020.10.004. Epub 2020 Oct 29.
6
Provisional case definitions for COVID-19-associated neurological disease.新型冠状病毒肺炎相关神经系统疾病的临时病例定义。
Lancet Neurol. 2020 Nov;19(11):890-891. doi: 10.1016/S1474-4422(20)30373-2.
7
Lessons from a neurology consult service for patients with COVID-19.针对新冠肺炎患者的神经科会诊服务经验教训。
Lancet Neurol. 2020 Oct;19(10):806-807. doi: 10.1016/S1474-4422(20)30316-1. Epub 2020 Sep 16.
8
Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants - (Ashwagandha), (Giloy) and (Tulsi) - a molecular docking study.通过阿育吠陀药用植物（ Ashwagandha ）、（ Giloy ）和（ Tulsi ）的活性植物化学成分靶向 COVID-19 （ SARS-CoV-2 ）主蛋白酶 - （ Ashwagandha ）、（ Giloy ）和（ Tulsi ） - 分子对接研究。
J Biomol Struct Dyn. 2022 Jan;40(1):190-203. doi: 10.1080/07391102.2020.1810778. Epub 2020 Aug 27.
9
Covid-19 and promising solutions to combat symptoms of stress, anxiety and depression.新冠疫情以及应对压力、焦虑和抑郁症状的可行解决方案。
Neuropsychopharmacology. 2021 Jan;46(1):217-218. doi: 10.1038/s41386-020-00791-9.
10
Neurological associations of COVID-19.新型冠状病毒肺炎的神经系统相关表现。
Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.
Zotero 插件